Benjamin M Scirica Selected Research

Ranolazine

1/2021	Plasma Omega-3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN-TIMI 36.
8/2015	Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN-TIMI 36 Trial.
1/2015	Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial.
7/2014	Relation of T-wave alternans to mortality and nonsustained ventricular tachycardia in patients with non-ST-segment elevation acute coronary syndrome from the MERLIN-TIMI 36 trial of ranolazine versus placebo.
6/2014	ECG morphological variability in beat space for risk stratification after acute coronary syndrome.
6/2014	Clinical features, use of evidence-based therapies, and cardiovascular outcomes among patients with chronic kidney disease following non-ST-elevation acute coronary syndrome.
4/2014	Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
7/2012	Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes.
1/2012	Role of ST2 in non-ST-elevation acute coronary syndrome in the MERLIN-TIMI 36 trial.
11/2011	Myocardial ischemia and ventricular tachycardia on continuous electrocardiographic monitoring and risk of cardiovascular outcomes after non-ST-segment elevation acute coronary syndrome (from the MERLIN-TIMI 36 Trial).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benjamin M Scirica Research Topics

Disease

86	Myocardial Infarction 11/2021 - 11/2003
56	Acute Coronary Syndrome 01/2021 - 11/2003
39	Heart Failure 10/2022 - 06/2006
31	Ischemia 01/2021 - 02/2006
29	Hemorrhage 01/2020 - 10/2006
26	Type 2 Diabetes Mellitus (MODY) 07/2022 - 11/2011
25	Diabetes Mellitus 01/2022 - 04/2009
23	Stroke (Strokes) 12/2019 - 09/2009
19	ST Elevation Myocardial Infarction 01/2018 - 07/2006
18	Peripheral Arterial Disease 10/2021 - 09/2009
17	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2009
15	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 02/2007
13	Atherosclerosis 10/2019 - 09/2009
12	Ischemic Stroke 01/2021 - 09/2009
10	Thrombosis (Thrombus) 01/2020 - 10/2006
9	Heart Arrest (Cardiac Arrest) 01/2022 - 12/2010
8	Myocardial Ischemia (Ischemic Heart Diseases) 07/2016 - 02/2007
7	Non-ST Elevated Myocardial Infarction 01/2018 - 10/2007
6	Chronic Renal Insufficiency 01/2021 - 06/2014
6	Unstable Angina 01/2018 - 10/2007
5	Albuminuria 01/2022 - 04/2015
5	Chronic Obstructive Pulmonary Disease (COPD) 10/2021 - 01/2018
5	Hypertension (High Blood Pressure) 10/2021 - 07/2012
5	Atrial Fibrillation 01/2021 - 01/2015
5	Overweight 01/2019 - 01/2018
5	Renal Insufficiency (Renal Failure) 01/2018 - 11/2003
5	Transient Ischemic Attack 03/2017 - 12/2014
4	Ventricular Tachycardia 01/2021 - 08/2010
4	Infections 01/2021 - 06/2006
4	Weight Loss (Weight Reduction) 01/2019 - 01/2018
4	Hypoglycemia (Reactive Hypoglycemia) 01/2018 - 04/2009
4	Cardiac Arrhythmias (Arrythmia) 02/2017 - 04/2007
4	Vascular Diseases (Vascular Disease) 12/2014 - 07/2012
3	Cardiomyopathies (Cardiomyopathy) 09/2022 - 04/2016
3	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2021 - 08/2010
3	Chest Pain (Chest Pains) 12/2020 - 02/2014
3	Coma (Comas) 12/2018 - 12/2010
3	Bradycardia 01/2018 - 05/2011
3	Cardiogenic Shock 04/2016 - 05/2011
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2014 - 04/2012
2	Diarrhea 01/2021 - 11/2010
2	Body Weight (Weight, Body) 10/2019 - 10/2019
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2016 - 12/2014
2	Pathologic Constriction (Stenosis) 03/2016 - 04/2010
2	Hyperglycemia 04/2015 - 04/2009

Drug/Important Bio-Agent (IBA)

24	Ranolazine FDA Link 01/2021 - 06/2006
23	vorapaxarIBA 10/2021 - 09/2009
23	Neurofibromin 2 (Merlin)IBA 01/2021 - 06/2006
22	saxagliptin FDA Link 11/2021 - 11/2011
18	Biomarkers (Surrogate Marker)IBA 11/2021 - 11/2003
18	Clopidogrel (Plavix)FDA Link 01/2020 - 07/2006
12	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2021 - 02/2007
11	TroponinIBA 12/2020 - 11/2003
10	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 04/2009
9	Thrombin Receptors (Thrombin Receptor)IBA 10/2021 - 12/2014
9	omega-Chloroacetophenone (Mace)IBA 10/2021 - 05/2011
9	TicagrelorIBA 01/2021 - 11/2007
8	SodiumIBA 09/2022 - 06/2006
7	Natriuretic PeptidesIBA 09/2022 - 08/2010
7	pro-brain natriuretic peptide (1-76)IBA 09/2022 - 03/2011
6	Troponin T (Troponin T1)IBA 11/2021 - 11/2003
5	dapagliflozinIBA 09/2022 - 10/2019
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 11/2010
5	PAR-1 ReceptorIBA 04/2019 - 09/2009
5	C-Reactive ProteinIBA 01/2019 - 10/2007
5	lorcaserinIBA 01/2019 - 01/2018
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 06/2006
4	aclidinium bromideIBA 10/2021 - 01/2018
4	Insulin (Novolin)FDA Link 01/2021 - 04/2015
4	Troponin IIBA 01/2021 - 03/2011
4	Pharmaceutical PreparationsIBA 12/2019 - 10/2006
4	CreatinineIBA 11/2019 - 03/2013
4	Thrombin FDA Link 10/2019 - 09/2009
4	5-HT2C Serotonin ReceptorIBA 01/2019 - 01/2018
4	Heparin (Liquaemin)FDA LinkGeneric 11/2010 - 10/2006
3	Muscarinic AntagonistsIBA 10/2021 - 01/2019
3	LipidsIBA 10/2021 - 01/2021
3	Prasugrel Hydrochloride FDA Link 01/2020 - 04/2008
3	AlbuminsIBA 11/2019 - 01/2018
3	Peptide Hydrolases (Proteases)FDA Link 03/2017 - 04/2013
3	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2017 - 09/2009
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2017 - 11/2011
3	CalciumIBA 10/2007 - 06/2006
3	MB Form Creatine KinaseIBA 02/2007 - 11/2003
2	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 01/2017
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 11/2017
2	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 01/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020 - 08/2016
2	empagliflozinIBA 12/2019 - 11/2017
2	PotassiumIBA 02/2017 - 01/2012
2	thienopyridineIBA 11/2015 - 06/2009
2	Blood Glucose (Blood Sugar)IBA 04/2015 - 12/2014

Therapy/Procedure

48	Therapeutics 10/2022 - 03/2005
16	Secondary Prevention 10/2021 - 10/2012
15	Percutaneous Coronary Intervention 01/2020 - 10/2006
8	Induced Hypothermia 01/2022 - 12/2010
6	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 03/2017 - 09/2009
4	Stents 01/2020 - 04/2008
2	Glycemic Control 01/2017 - 11/2011
2	Resuscitation 05/2016 - 12/2010